Feedback PLC Result of AGM (4448R)
2023年10月26日 - 10:24PM
ＲＮＳを含む英国規制内ニュース （英語）
TIDMFDBK
RNS Number : 4448R
Feedback PLC
26 October 2023
Feedback plc
Result of AGM
Feedback plc (AIM: FDBK, "Feedback" or the "Company"), the
clinical infrastructure specialist, announces that at the Annual
General Meeting ("AGM") held today all resolutions were duly
passed.
The results of the poll (including proxy votes on the
resolutions) are included below.
Resolutions Votes For** % of votes Votes Against % of votes Votes Total votes
cast*** cast*** Withheld*** cast***
1) To receive
the report
and accounts
for the year
ended 31 May
2023. 6,796,610 99.94 4,120 0.06 64 6,800,730
------------ --------------- -------------- --------------- ---------------- ---------------
2) To receive
the
remuneration
report of
the Company
for the year
ended 31 May
2023. 6,793,069 99.89 7,661 0.11 64 6,800,730
------------ --------------- -------------- --------------- ---------------- ---------------
3) To
re-elect
Adam Denning
as a
Director of
the Company. 6,794,360 99.91 6,370 0.09 64 6,800,730
------------ --------------- -------------- --------------- ---------------- ---------------
4) To
re-elect
Philipp
Prince as a
Director of
the Company. 6,794,360 99.91 6,370 0.09 64 6,800,730
------------ --------------- -------------- --------------- ---------------- ---------------
5) To
re-appoint
Price Bailey
LLP as
Auditor of
the Company. 6,796,610 99.94 4,120 0.06 64 6,800,730
------------ --------------- -------------- --------------- ---------------- ---------------
6) To
authorise
the
Directors to
determine
the fees
payable to
the Auditor. 6,796,610 99.94 4,120 0.06 64 6,800,730
------------ --------------- -------------- --------------- ---------------- ---------------
Special Business
7) To
authorise
the
Directors to
allot equity
securities. 6,794,094 99.90 6,636 0.10 64 6,800,730
------------ --------------- -------------- --------------- ---------------- ---------------
Special
Resolution
8) To
empower the
Directors to
allot equity
securities
for cash
free of
statutory
pre-emption
rights. 6,794,093 99.90 6,636 0.10 65 6,800,729
------------ --------------- -------------- --------------- ---------------- ---------------
Special
resolution
9) To
empower the
Directors to
allot equity
securities
for cash
otherwise
than on a
pre-emptive
basis for an
acquisition
or other
capital
investment. 6,794,093 99.90 6,636 0.10 65 6,800,729
Notes:
* "Votes For" include votes giving the Chairman discretion.
** Percentages exclude "Votes Withheld".
*** "Votes Withheld" are not votes in law and do not count in
the number of votes counted for or against a resolution.
**** "Total votes cast" do not include withheld votes.
-Ends-
Enquiries:
Feedback plc +44 (0) 20 3997 7634
Tom Oakley, CEO IR@fbk.com
Anesh Patel, CFO
Panmure Gordon (UK) Limited
(NOMAD and Broker)
Emma Earl/Freddy Crossley (Corporate
Finance)
Rupert Dearden (Corporate Broking) +44 (0)20 7886 2500
Walbrook PR Ltd; Tel: 020 7933 8780 or feedbackplc@walbrookpr.com
Nick Rome/Joe Walker 07748 325 236 or 07407 020 470
About Feedback
Feedback plc helps clinical teams to make better decisions
faster for patients. We design products that enhance clinician
access to patient data and to their colleagues. Our unique approach
centres around individual patient episodes, into which we pull
relevant clinical data from hospital systems and around which we
build remote clinical teams for collaboration. As a result, we
produce a digital infrastructure that makes patient data available
to clinicians in multiple settings, in a format that enables them
to meaningfully interact with it, providing flexibility to
clinicians and free movement of patients between provider settings
- clinicians can practice from anywhere and patients can attend any
care provider for treatment.
Our products Bleepa and CareLocker work together to deliver
unparalleled value to our customers. Bleepa is our application
layer and sits on top of CareLocker as our data layer. Bleepa is a
clinician facing platform that displays clinical results from a
patient's CareLocker at a certified and regulated quality, that is
suitable for clinical use and enables dialogue on a
patient-by-patient basis with colleagues through a secure,
auditable chat interface that links back to the patient medical
record. The CareLocker data storage model is built around the
patient. Our vision is one where relevant clinical data is always
available to the patient as well as to any care setting that they
may attend - a federated data architecture with the patient as the
tenant.
The Company has a number of growth opportunities domestically
and internationally across a range of markets including the NHS,
the veterinary market and private healthcare providers and its
highly scalable Software as a Service ("SaaS")-based model is
expected to provide increasing levels of revenue visibility as the
Company grows its customer base.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
RAGXQLFLXBLLFBX
(END) Dow Jones Newswires
October 26, 2023 09:24 ET (13:24 GMT)
Feedback (LSE:FDBK)
過去 株価チャート
から 2 2025 まで 3 2025
Feedback (LSE:FDBK)
過去 株価チャート
から 3 2024 まで 3 2025
